Allarity Therapeutics Inc. (NASDAQ: ALLR) announced its active pharmaceutical ingredient manufacturing campaign for stenoparib is proceeding according to schedule for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE